Published in

Springer, PharmacoEconomics, 11(38), p. 1263-1275, 2020

DOI: 10.1007/s40273-020-00951-1

Links

Tools

Export citation

Search in Google Scholar

Simulating Progression-Free and Overall Survival for First-Line Doublet Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients Based on Real-World Registry Data

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO